CLINICAL_TRIALS trial_result · 2021-03-16

Clinical Trial Update: Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma [Phase 2]

Phase 2 clinical trial comparing F-18 FDG and C-11 acetate PET in multiple myeloma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Michael C Roarke, MD | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-03-16